![]() ![]() The defendants made several arguments against centralizing the cases. The centralization of the lawsuits will allow the court to significantly streamline pretrial proceedings, reduce the expense associated with duplicative discovery and conflicting pretrial obligations and rulings on similar motions. The motion informed the Panel that there were 38 potential tag-along actions. The litigation includes 10 lawsuits pending in six districts, but according to the plaintiffs’ counsel, has the potential to include many more cases. The multidistrict litigation will be looking at whether the design of the Bard port catheters requires too high a concentration of barium sulfate, as well as whether the defendant’s tested the devices sufficiently and whether they appropriately monitored and reported adverse events related to product failures.Ī 2021 report determined that there is a 59% complication rate with these devices. This concentration, purportedly, reduces the catheter’s material integrity, which can in turn result in fracture or migration of the catheter, infection, and thrombosis. They found that the common factual questions involve allegations that there is too great a concentration of barium sulfate used during the manufacturing of the catheter in the port devices. The Panel determined that the lawsuits involved common questions of fact and that just and efficient litigation would be promoted by centralizing the case in the District of Arizona. Billions have been recovered in product liability lawsuits around the country with which we’ve been involved. If you or a loved one suffered harm as a result of a Bard Power Port device, you should call the seasoned Chicago-based attorneys of Moll Law Group about your potential claim. They allege that due to the catheters on the devices breaking, they suffered blood clots, infections, chest pain, and other life-threatening complications many of them needed to undergo emergency surgeries to extract pieces of catheter. § 1407 to centralize litigation arising out of Bard’s Power Port devices in the Western District of Missouri. Bard, Inc., and Bard Access Systems made a motion under 28 U.S.C. Recently, plaintiffs in eight lawsuits against Becton, Dickinson & Company, C.R. These are two-part devices with an injection reservoir and a catheter. Bard’s PowerPort devices are implanted under the skin and pump intravenous chemotherapy and other fluid into a patient’s bloodstream.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |